title: US Food and Drug Administration's review of the novel antidepressant vortioxetine.
authors: Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market St, Ste 670, Philadelphia, PA 19104 thase@mail.med.upenn.edu.
authors: Michael E
authors: ME
authors: Thase
mesh_terms: D003865:Major Depressive Disorder / Q000188:drug therapy*; D017277:Drug Approval; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines; D017367:Selective Serotonin Reuptake Inhibitors; D013440:Sulfides; D014486:United States Food and Drug Administration / Q000592:standards*; D000078784:Vortioxetine
chemical_list: D010879:Piperazines; D017367:Selective Serotonin Reuptake Inhibitors; D013440:Sulfides; D000078784:Vortioxetine